MDLZ
67
16
ABBV
60
-2
IPG
45
-4
ABT
63
3
TXT
60
4
XRAY
19
2
DRI
77
5
HST
37
5
HOG
47
4
PHM
57
5
COF
64
2
MAR
35
2
D
25
-3
THC
61
6
PWR
60
4
EQIX
57
4
SWKS
43
3
GE
67
2
MPC
44
2
EBAY
43
-9
MDLZ
67
16
ABBV
60
-2
IPG
45
-4
ABT
63
3
TXT
60
4
XRAY
19
2
DRI
77
5
HST
37
5
HOG
47
4
PHM
57
5
COF
64
2
MAR
35
2
D
25
-3
THC
61
6
PWR
60
4
EQIX
57
4
SWKS
43
3
GE
67
2
MPC
44
2
EBAY
43
-9
Financhill
Back

Amphastar Pharmaceuticals 10K Form

Sell
41

AMPH
Amphastar Pharmaceuticals

Last Price:
$28.27
Seasonality Move:
15.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AMPH News And Ratings

See the #1 stock for the next 7 days that we like better than AMPH

AMPH Financial Statistics

Sales & Book Value

Annual Sales: $732M
Cash Flow: $16.6M
Price / Cash Flow: 8.6
Annual Sales: $15.38
Price / Book: 1.85

Profitability

EPS (TTM): 3.06000
Net Income (TTM): $159.5M
Gross Margin: $373.9M
Return on Equity: 22.89%
Return on Assets: 10.36%

Amphastar Pharmaceuticals Earnings Forecast

Key Amphastar Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 22 years for AMPH is 51.08%.
  • The Selling, General & Administrative Expenses for AMPH have been equal to 12.91% of Gross Profit Margin.
  • The Research & Development expenses have been 10.10% of Revenue.
  • The Interest Expense is 19.02% of Operating Income.
  • The Net Earning history of AMPH is 21.79% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 11 years.

Amphastar Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: AMPH
CUSIP: 03209R
Website: amphastar.com

Debt

Debt-to-Equity Ratio: 0.82
Current Ratio: 3.07
Quick Ratio: 2.07

Price-to-Earnings

Trailing P/E Ratio: 9.3
Forward P/E Ratio: 7.61

AMPH Technical Analysis vs Fundamental Analysis

Sell
41
Amphastar Pharmaceuticals (AMPH) is a Sell

Is Amphastar Pharmaceuticals a Buy or a Sell?